London Regenerative Medicine Network

	London Regenerative Medicine Network 'Bringing the regenerative medicine, stem cell and tissue engineering community together'

News

Next Event

Next Event

Calendar

Sponsors

Date	Speaker	Title
June 2010	Dr. Roger Barker, Addenbrooke?s Hospital, Cambridge	Cell therapies and Parkinson's disease: where next?
	Prof. Ernest Arenas, Karolinska Institute, Sweden	A Wnt code controls midbrain dopaminergic neuron development & stem cell differentiation
	Prof. Arnold Kriegstein, University of California, San Francisco	A cell-based strategy to modify circuit activity in Parkinson's disease
May 2010	Martin McGlynn, StemCells Inc	Human CNS stem cell therapeutics program: challenges, strategy and progress to date
	Robert Klein	A funding model for regenerative medicine
April 2010	Christopher Bravery, Consulting on Advanced Biologicals Ltd	Should autologous cell therapy companies have the right to refuse treatment to patients?
	Richard Snell, Altrika Ltd	The use of novel materials for regenerative medicine applications
	Gil Beyen, TiGenix NV	ChondroCelect©, the first cell-based product approved by the EMEA
March 2010	Hutan Ashrafian, Imperial College London	Auto-bionics ? a new paradigm in regenerative medicine and surgery
	Anthony H Davies, Geron Corporation	Scaling of hESC-derived therapeutics manufacturing
	Robert J Deans, Athersys Inc	Adult adherent stem cells in the treatment of cardiovascular injury: development considerations and clinical experience
February 2010	James Lawford-Davies, Lawford-Davies Denoon	The history and ABC guide to embryonic stem cell regulation
	Glyn Stacey, UK Stem Cell Bank	Meeting the challenge of delivering the UK Stem Cell Bank project
	Dr Tom Okarma, Geron Corp	Human embryonic stem cell therapy: pathway to the clinic
January 2010	Dr. Mary Archer, Cambridge University Hospitals NHS Foundation Trust
	Prof. Robin Franklin, MRC Centre for Stem Cell Biology and Regenerative Medicine, & Department of Veterinary Medicine, University of Cambridge	Regenerative medicine and multiple sclerosis
	Prof. Gianvito Martino MD, University Vita-Salute San Raffaele, Milan, Italy	Cell therapy for MS: the potential of transplanted neural stem & precursor cells
December 2009	Vern Liebmann, MBA, Aderans Research	Challenges of mass manufacturing during the clinical phase of cell-based products
	Robert Cavorsi, Organogenesis	Developing the pricing and reimbursement strategy for cell-based therapie
	Dr Todd McAllister, Cytograft Tissue Engineering	Overcoming key challenges to the commercial translation of cell therapies
November 2009	Dr Donald Coppen, Biocompatibles International plc	CellBeads ? a novel, clinical-stage approach for extended local drug delivery
	Dr Julie Daniels, Department of Ocular Biology & Therapeutics, UCL Institute of Ophthalmology	Stem cell therapy for blinding ocular surface diseases
	Gregg Sando, Cell Medica Ltd	Commercialising adoptive cellular immunotherapy for the treatment of infectious disease in immunosuppressed patients
October 2009	Prof Anthony Mathur, Barts and the London NHS Trust	The REGENERATE clinical trials of Cell Therapy in Cardiac Disease
	Prof Paul Sharpe, Department of Craniofacial Development, Dental Institute, Kings College London	Biological replacement of teeth
	Sir Richard Sykes DSc FRS FMedSci, NHS London and Chairman of the Board of Trustees, UKSCF	The UK Stem Cell Foundation - Translating British science into patient therapies by bridging the funding gap
June 2009	Prof Kevin Warwick, University of Reading	The Cyborg Experiments
	Prof Jeremy Brockes, Dept of Structural & Molecular Biology, UCL	Limb regeneration in an adult vertebrate
	Dr Jane Lebkowski, Geron Corporation	Development of human embryonic stem cells for therapeutic applications
June 2009	Prof Kevin Shakesheff, University of Nottingham	Delivering cells and proteins: Scientific and Intellectual Property Opportunities
	Dr Aubrey de Grey, SENS Foundation	Regenerative therapies against aging: can they be comprehensive enough?
	Prof. Philippe Menasché, University of Paris Descartes	Ian Rosenberg Memorial Lecture - Cell-Based Therapy for Cardiac Repair
May 2009	Geoff MacKay, Organogenesis	Commercialisation of Living Cell Therapies to Induce Soft Tissue Regeneration
	Michael Siani-Rose, Theregen Inc.
	Nicolas L'Heureux	Heart Muscle Regenerative Therapy
April 2009	Prof. Mark Ferguson, Renovo	Development of novel pharmaceuticals to prophylactically improve scarring
	Prof.Geoff Raisman FRS, UCL Institute of Neurology	Repair of brain and spinal cord by transplantation of olfactory ensheathing cells cultured from adult stem cells
	Dr Suwan Jayasinghe, BioPhysics Group, Dept Mechanical Engineering, UCL	Bio-electrosprays and cell electrospinning:novel direct strategies for tissue engineering and regenerative biology/medicine
March 2009	Dr. Mark Lewis, UCL Eastman Dental Institute	Cell Therapy: View from the front line ? an academic experience
	Dr. Rosemary Drake, The Automation Partnership	Automation: Is this the route to successful scale-up and manufacture of cell-based therapies?
	Dr. Eric Daniels, Cytori Therapeutics	Adipose-derived regenerative cells: Current clinical applications
February 2009	Mark Henderson - The Times Andy Coghlan - New Scientist Fiona Fox - Science Media Centre	Panel Session - Implications for the Government, NHS and patients on the recent approval by the FDA to allow human embryonic stem cell clinical trials to proceed.
	Prof John Martin, Centre for Cardiovascular Biology & Medicine, BHF Laboratories, University College London	Is there a future for gene therapy?
	Dr. Darren Bhattachary, BMRB	Stem cells: implications of public and stakeholders' views on the science and ethics.
January 2009	Dr Nick Skaer, Orthox Ltd	Regenerative Silk-based Scaffolds for Orthopaedic Tissue Repair
	Mr Alex J Shortt MRCOphth, Hillingdon Hospital NHS Trust	Genetic Regulation of Corneal Limbal Epithelial Stem Cells and the Implications for Restoring Vision
	Prof. Herbert Gottweis, Department of Political Science, University of Vienna	The Politics of Regenerative Medicine: Challenges Ahead
December 2008	Dr Evan Harris MP, Oxford West and Abingdon	Glass half-empty: Unfinished business from the Human Embryology Act
	Prof. Nagy Habib, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics	Clinical application of adult bone marrow-derived stem cell progenitors
	Prof. Anthony Hollander, University Of Bristol	Claudia's trachea: Lessons learned for future regenerative medicine strategies
November 2008	Dr. Steven Bauer, CBER, FDA	Stem Cells and Regenerative Medicine: An FDA Perspective
	Greg Bonfiglio, Proteus Venture Partners	Commercialising Regenerative Medicine: Moving Great Science from Bench to Bedside
	Geoff MacKay, Organogenesis	Applying Living Technology for Soft Tissue Regeneration: R+D, Manufacturing + Commercialisation
October 2008	Prof. Pete Coffey, The London Project to Cure Blindness	The London Project to Cure Blindness: Stemming Vision Loss with Stem Cells
	James Lawford Davies, Clifford Chance, London	497 Days of Law-Making in Regenerative Medicine
	David Macauley, Virgin Health Bank	Planes, Trains and Umbilical Cord Blood Stem Cells

Previous speakers from 2005 to 2007